Bydureon Bcise - NDC Database
1 record found
Page:
0310-6540 Dec 01, 2017
Bydureon Bcise 2 mg/.85ml Subcutaneous Injection, Suspension, Extended Release by Astrazeneca Pharmaceuticals Lp
Bydureon Bcise 2 mg/.85ml Subcutaneous Injection, Suspension, Extended Release by Astrazeneca Pharmaceuticals Lp
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.